切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2010, Vol. 04 ›› Issue (04) : 319 -322. doi: 10.3877/cma.j.issn.1674-0793.2010.04.007

所属专题: 文献

论著

紫杉醇在大鼠原位肝移植中的作用及其对细胞毒性T淋巴细胞实验的影响
郭卫平1, 卫洪波1, 李玺1, 陈图峰1, 汪根树1, 陈规划1,()   
  1. 1. 510630 广州,中山大学附属第三医院普通外科
  • 收稿日期:2010-03-10 出版日期:2010-08-01
  • 通信作者: 陈规划

Effect of paclitaxol in rat orthotopic liver transplantation and its impact on the CTL

Wei-ping GUO1, Hong-bo WEI1, Xi LI-1, Tu-feng CHEN1, Gen-shu WANG1, Gui-hua CHEN1,()   

  1. 1. Department of Gastrointestinal Surgery, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China
  • Received:2010-03-10 Published:2010-08-01
  • Corresponding author: Gui-hua CHEN
  • About author:
    Corresponding author: CHEN Gui-hua, Email:
引用本文:

郭卫平, 卫洪波, 李玺, 陈图峰, 汪根树, 陈规划. 紫杉醇在大鼠原位肝移植中的作用及其对细胞毒性T淋巴细胞实验的影响[J/OL]. 中华普通外科学文献(电子版), 2010, 04(04): 319-322.

Wei-ping GUO, Hong-bo WEI, Xi LI-, Tu-feng CHEN, Gen-shu WANG, Gui-hua CHEN. Effect of paclitaxol in rat orthotopic liver transplantation and its impact on the CTL[J/OL]. Chinese Archives of General Surgery(Electronic Edition), 2010, 04(04): 319-322.

目的

观察紫杉醇在大鼠原位肝移植中的作用及其对细胞毒性T淋巴细胞(CTL)的影响。

方法

建立Wistar→SD大鼠肝移植的急性排斥模型。将大鼠分为对照组(阻断全肝血流)、急排组(Wistar→SD肝移植)、紫杉醇组(Wistar→SD肝移植,紫杉醇腹腔注射0.75 mg·kg-1·d-1,观察生存时间、病理改变、生化指标及CTL、T淋巴细胞凋亡情况。

结果

紫杉醇组大鼠的术后存活时间高于急排组,[(18.2±1.5)d vs(8.8±1.9)d,P<0.01)。急排组的HE评分(Banff)高于紫杉醇组(7.80±0.83 vs 4.80±0.82,P<0.01)。紫杉醇组的白蛋白水平高于急排组(P=0.003);紫杉醇组的谷丙转氨酶水平低于急排组(t=25.23,P<0.01)。CTL检测中,急排组的特异性杀伤靶细胞的百分率均高于紫杉醇组(P<0.01)。急排组的T淋巴细胞的凋亡率低于紫杉醇组[(7.16±1.56)% vs(16.47±2.51)%,P<0.01]。

结论

紫杉醇在大鼠肝移植中具有免疫抑制作用,可能通过诱导T淋巴细胞凋亡来抑制T淋巴细胞的活化发挥作用。

Ojective

To observation of the effect of paclitaxol in rat orthotopic liver transplantation and its impact on the cytotoxic T lymphocyte (CTL).

Methods

Wistar → SD rat liver transplantation model of acute rejection was established. The rats were divided into three groups: control group (blocking total hepatic blood flow), acute rejection group (Wistar → SD liver transplantation), paclitaxel group (Wistar → SD liver transplantation, paclitaxel intraperitoneal injection of 0.75 mg·kg-1·d-1. The survival time, pathological changes, biochemical markers and CTL, T lymphocyte apoptosis were observed.

Results

The postoperative survival time of paclitaxel group were rats higher than acute rejection group, (18.2±1.5)d vs(8.8± 1.9) d, P<0.01. HE score (Banff) of acute rejection group is higher than the paclitaxel group, 7.80±0.83 vs 4.80±0.82, t=5.67, P<0.01. Albumin level in paclitaxel group ranked higher than acute rejection group, P=0.003, while alanine aminotransferase of paclitaxel group were lower than acute rejection group, P<0.01. In CTL, the percentage of anti-target cell in acute rejection group were higher than the percentage of paclitaxel group, P<0.01. Tlymphocyte apoptosis rate of acute rejection group isless than the paclitaxel group, (7.16±1.56)% vs(16.47±2.51)%, P<0.01.

Conclusion

Paclitaxel exerts immunosuppression in rat liver transplantation, by inducing T lymphocyte apoptosis to suppress T lymphocyte activation probably.

图1 对照组的病理结果(HE染色20×10)
图2 急排组的病理结果(HE染色40×10)
图3 紫杉醇组病理结果(HE染色20×10)
图4 各组在CTL特异性杀伤靶细胞的百分率
图5 对照组的T淋巴细胞凋亡情况(AnnexinV+PI-:5.21%)
图6 急排组的T淋巴细胞凋亡情况(AnnexinV+PI-:6.86%)
图7 紫杉醇组的T淋巴细胞凋亡情况(AnnexinV+PI-:17.51%)
1
Dezube BJ. New therapies for the treatment of AIDS-related Kaposi sarcoma. Curr Opin Oncol,2000,12(5):445-449.
2
Figgitt DP, Wiseman LR. Docetaxel: an update of its use in advanced breast cancer. Drugs,2000,59(3):621-651.
3
Iesalnieks I, Tange S, Scherer MN,et al. Paclitaxel promotes liver graft survival in rats and inhibits hepatocellular carcinoma growth in vitro and is a potentially useful drug for transplant patients with liver cancer. transplant Proc,2002,34(6):2316-2317.
4
Tange S, Scherer MN, Graeb C,et al. The antineoplastic drug Paclitaxel has immunosuppressive properties that can effectively promote allograft survival in a rat heart transplant model. Transplantation,2002,73(2):216-223.
5
Lee M, Yea SS, Jeon YJ. Pachtaxel causes mouse splenic lymphocytes to a state hyporesponsiveness to lipopolysaccharide stimulation. Int J Immunopharmacol,2000,22(8):615-621.
6
Geissler EK, Graeb C, Tange S,et al. Effective use of donor MHC class I gene therapy in organ transplantation: prevention of antibody-mediated hyperacute heart allograft rejection in highly sensitized rat recipients. Hum Gene Ther,2000,11(3):459.
7
Reyes-Corona J, Gonzalez-Huezo MS, Zea-Medina MV,et al. Paclitaxel coated-stent for early-onset thrombosis after liver transplantation. Ann Hepatol,2007,6(4):272-275.
8
Lee BH, Lee JE, Lee KW,et al. Coating with paclitaxel improves graft survival in a porcine model of haemodialysis graft stenosis. Nephrol Dial Transplant,2007,22(10):2800-2804.
9
Le Moine A, Goldman M, Abramowicz D. Multiple pathways to allograft rejection. Transplantation,2002,73(9):1373-1381.
10
Yu B, Kusmartsev S, Cheng F,et al. Effective combination of chemotherapy and dendritic cell administration for the treatment of advanced-stage experimental breast cancer. Clin Cancer Res,2003,9(1):285-294.
11
Vicari AP, Luu R, Zhang N,et al. Paclitaxel reduces regulatory T cell numbers and inhibitory function and enhances the anti-tumor effects of the TLR9 agonist PF-3512676 in the mouse. Cancer Immunol,2009,58(4):615-628.
[1] 刘思锐, 赵辰阳, 张睿, 张一休, 杨萌. 多普勒超声对孕鼠子宫动脉不同节段血流动力学参数的评估[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 877-883.
[2] 陈进宏. 腹腔镜活体供肝获取规范与创新[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 324-324.
[3] 中华医学会器官移植学分会, 中国医师协会器官移植医师分会. 中国活体肝移植供者微创手术技术指南(2024版)[J/OL]. 中华普通外科学文献(电子版), 2024, 18(04): 241-252.
[4] 胡宁宁, 赵延荣, 王栋, 王胜亮, 郭源. FMNL3与肝细胞癌肝移植受者预后的相关性研究[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 283-288.
[5] 仲福顺, 余露, 范晓礼, 叶啟发. 肝移植治疗肝上皮样血管内皮瘤一例[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 293-297.
[6] 刘冉佳, 崔向丽, 周效竹, 曲伟, 朱志军. 儿童肝移植受者健康相关生存质量评价的荟萃分析[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 302-309.
[7] 贺健, 张骊, 王洪海, 蒋文涛. 肝移植术后脾功能亢进转归及治疗研究进展[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 310-314.
[8] 黄建朋, 邹建强, 宗华. 肝移植术后腹壁疝诊治初步经验[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(04): 471-473.
[9] 刘锦程, 王斌, 张雯, 张明周, 刘禹, 叶东樊, 黄赞胜, 邱凌霄, 卿斌, 王创业, 王南博, 王苹, 郭宇航, 周培花, 程秋霞, 徐智. 肺泡灌洗液RASSF1A及SHOX2甲基化联合径向超声特征对肺结节性质鉴别诊断的意义[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 505-511.
[10] 中华医学会器官移植学分会. 肝移植术后缺血性胆道病变诊断与治疗中国实践指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 739-748.
[11] 傅斌生, 冯啸, 杨卿, 曾凯宁, 姚嘉, 唐晖, 刘剑戎, 魏绪霞, 易慧敏, 易述红, 陈规划, 杨扬. 脂肪变性供肝在成人劈离式肝移植中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 789-794.
[12] 魏志鸿, 刘建勇, 吴小雅, 杨芳, 吕立志, 江艺, 蔡秋程. 肝移植术后急性移植物抗宿主病的诊治(附四例报告)[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 846-851.
[13] 中华医学会器官移植学分会, 中华医学会外科学分会外科手术学学组, 中华医学会外科学分会移植学组, 华南劈离式肝移植联盟. 劈离式供肝儿童肝移植中国临床操作指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 593-601.
[14] 刘军, 丘文静, 孙方昊, 李松盈, 易述红, 傅斌生, 杨扬, 罗慧. 在体与离体劈离式肝移植在儿童肝移植中的应用比较[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 688-693.
[15] 张红君, 郑博文, 廖梅, 任杰. 超声及超声造影在肝移植术后上腹部淋巴结良恶性鉴别诊断中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(04): 562-567.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?